No axonal or amyloid-based neurodegeneration was detected in one delirium patient with NMDAR antibodies, as his normal values were below the cut-off levels for tau protein, tau 181, Aß42, Aß40, the Aß42/40 ratio. The gene discussed is MAPT; the disease is delirium.